Endexx

Endexx EBIT Growth

The Year-over-Year EBIT Growth of Endexx (EDXC) as of Nov 22, 2026 is 31.72 %. In the previous year, Year-over-Year EBIT Growth was -44.49 % — a change of -171.31% (higher).

EBIT Growth

31.72 %

YoY

-171.31%

Last updated:

Year-over-Year EBIT Growth of Endexx is 2022 31.72 % . Year-over-Year EBIT Growth of Endexx was 2021 -44.49 % . It decreases by -171.31% higher compared to the previous year.

The Endexx EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2019
-261.08 USD
Jan 1, 2020
-0.21 USD
Jan 1, 2021
-44.49 USD
Jan 1, 2022
31.72 USD
The Endexx EBIT Growth history
YEAREBIT GrowthYoY
31.72 %-171.31%
-44.49 %+21,058.08%
-0.21 %-99.92%
-261.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Endexx Stock analysis

What does Endexx do? Endexx Corp. develops hemp-derived cannabidiol-based products through its subsidiaries, selling oils, extracts, topicals, and pet products via its e-commerce site cbdunlimited.com and other online and in-store retailers. The Gorilla-Tek division provides an automated dispensing system for secure distribution of hemp-based products. Seed-to-Shelf offers compliance and inventory tracking technology for regulated hemp product management. The company targets consumers seeking therapeutic relief for pain and inflammation, as well as retailers and pharmacies needing regulatory support systems. Endexx Corp. generates revenue from direct sales of CBD products through its website and retail partners, automated dispensing systems sold to businesses, and technology solutions like Seed-to-Shelf for industry compliance. Its consumer products are marketed to individuals and pet owners, while its technology services are sold to hemp industry businesses requiring regulatory and operational support. The company's subsidiaries handle product development, retail distribution, and technology services for the hemp sector. The firm's primary revenue streams include e-commerce sales of CBD oils, extracts, topicals, and pet products, automated dispensing systems for secure product distribution, and technology platforms such as Seed-to-Shelf for compliance and inventory management. These offerings cater to both end consumers and business clients in the hemp industry, with the Gorilla-Tek division focusing on dispensing solutions and Seed-to-Shelf supporting pharmacy and retail operations through process management systems. Endexx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Endexx stock

Year-over-Year EBIT Growth of Endexx is 31.72 % in 2022.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Endexx since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Endexx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Endexx

All Key Metrics — Endexx